Functional and clinicopathological studies associated with ERG-related miRNAs (i.e., miR-4638-5p) and pathways could provide new information into the pathogenesis of DLBCL and reveal novel targets for the management of patients with DLBCL [113]. This evidence concerns the gene ERG and diffuse large B-cell lymphoma.